Abstract
Dietary potassium-supplementation has been associated with a decreased risk of hypertension and other cardiovascular outcomes. However, blood pressure (BP) responses to potassium supplementation vary among individuals. This study was designed to examine the association between 12 single nucleotide polymorphisms (SNPs) in the adducin 1 alpha (ADD1) and guanine nucleotide binding protein (G protein) beta polypeptide 3 (GNB3) genes and systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) responses to potassium-supplementation. We conducted a 7-day high-sodium intervention (307.8 mmol sodium/day) followed by a 7-day high-sodium with potassium-supplementation (60 mmol potassium/day) among 1906 Han Chinese participants from rural north China. BP measurements were obtained at the end of each intervention period using a random-zero sphygmomanometer. We identified significant associations between ADD1 variant rs17833172 and SBP, DBP, and MAP responses to potassium-supplementation (all P < 0.0001) that remained significant after adjustment for multiple comparisons. In participants that were heterozygous or homozygous for the G allele of this marker, SBP, DBP, and MAP response to potassium-supplementation were − 3.52 ( − 3.82, − 3.21), − 1.41 ( − 1.66, − 1.15) and − 2.12 ( − 2.37, − 1.87), respectively, as compared to the corresponding responses of 1.99 (0.25, 3.73), − 0.65 ( − 0.10, − 0.21), and − 0.23 ( − 0.37, 0.83), respectively, for those who were homozygous for A allele. In addition, participants with at least one copy of the G allele of rs12503220 of the ADD1 gene had significantly increased DBP and MAP response to potassium-supplementation (P = 0.0041 and 0.01, respectively), which was also significant after correction for multiple testing. DBP and MAP responses to potassium-supplementation were − 1.36 ( − 1.63, − 1.10) and − 2.07 ( − 2.32, − 1.82) for those with at least G allele compared to corresponding responses of 0.86 ( − 0.68, 2.40) and − 0.45 ( − 1.74, 0.84) for those who were homozygous for A allele. In summary, our study identified novel associations between genetic variants of the ADD1 gene and BP response to potassium-supplementation, which could have important clinical and public health implications. Future studies aimed at replicating these novel findings are warranted.
Similar content being viewed by others
References
Adrogue H J, Madias N E. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med, 2007, 356(19): 1966–1978
Iwamoto T, Kita S. Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase. Kidney Int, 2006, 69(12): 2148–2154
O’shaughnessy K M, Karet F E. Salt handling and hypertension. J Clin Invest, 2004, 113(8): 1075–1081
He F J, MacGregor G A. Fortnightly review: Beneficial effects of potassium. BMJ, 2001, 323(7311): 497–501
He J, Gu D, Chen J, Jaquish C E, Rao D C, Hixson J E, Chen J C, Duan X, Huang J F, Chen C S, Kelly T N, Bazzano L A, Whelton P K; GenSalt Collaborative Research Group. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens, 2009, 27(1): 48–54
Whelton P K, He J, Cutler J A, Brancati F L, Appel L J, Follmann D, Klag M J. Effects of oral potassium on blood pressure. Metaanalysis of randomized controlled clinical trials. JAMA, 1997, 277(20): 1624–1632
Gu D, He J, Wu X, Duan X, Whelton P K. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens, 2001, 19(7): 1325–1331
Marteau J B, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens, 2005, 23(12): 2127–2143
Beeks E, Kessels A G, Kroon A A, van der Klauw M M, de Leeuw P W. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens, 2004, 22(7): 1243–1249
Bianchi G, Ferrari P, Staessen J A. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension, 2005, 45(3): 331–340
Manunta P, Citterio L, Lanzani C, Ferrandi M. Adducin polymorphisms and the treatment of hypertension. Pharmacogenomics, 2007, 8(5): 465–472
Beeks E, Janssen R G, Kroon A A, Keulen E T, Geurts J M, de Leeuw P W, de Bruin T W. Association between the alpha-adducin Gly460Trp polymorphism and systolic blood pressure in familial combined hyperlipidemia. Am J Hypertens, 2001, 14(12): 1185–1190
Bagos P G, Elefsinioti A L, Nikolopoulos G K, Hamodrakas S J. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens, 2007, 25(3): 487–500
GenSalt: rationale, design, methods and baseline characteristics of study participants. J Hum Hypertens, 2007, 21(8): 639–646
Perloff D, Grim C, Flack J, Frohlich E D, Hill M, McDonald M, Morgenstern B Z. Human blood pressure determination by sphygmomanometry. Circulation, 1993, 88(5 Pt 1): 2460–2470
International HapMap Consortium. The International HapMap Project. Nature, 2003, 426(6968): 789–796
Hinds D, Risch M. The ASPEX package: affected sib-pair exclusion mapping v1.88, 1999
Abecasis G R, Cherny S S, Cookson W O, Cardon L R. GRR: graphical representation of relationship errors. Bioinformatics, 2001, 17(8): 742–743
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M A, Bender D, Maller J, Sklar P, de Bakker P I, Daly M J, Sham P C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet, 2007, 81(3): 559–575
O’Connell J R, Weeks D E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet, 1998, 63(1): 259–266
Abecasis G R, Cherny S S, Cookson W O, Cardon L R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. [see comment]. Nat Genet, 2002, 30(1): 97–101
Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc, Series B (Methodological), 1995, 57(1): 289–300
Gerhard T, Gong Y, Beitelshees A L, Mao X, Lobmeyer M T, Cooper-DeHoff R M, Langaee T Y, Schork N J, Shriver M D, Pepine C J, Johnson J A; INVEST Investigators. Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES). Am Heart J, 2008, 156(2): 397–404
Manunta P, Cusi D, Barlassina C, Righetti M, Lanzani C, D’Amico M, Buzzi L, Citterio L, Stella P, Rivera R, Bianchi G. Alphaadducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int, 1998, 53(6): 1471–1478
Schorr U, Blaschke K, Beige J, Distler A, Sharma A M. G-protein beta3 subunit 825T allele and response to dietary salt in normotensive men. J Hypertens, 2000, 18(7): 855–859
Daimon M, Sato H, Sasaki S, Toriyama S, Emi M, Muramatsu M, Hunt S C, Hopkins P N, Karasawa S, Wada K, Jimbu Y, Kameda W, Susa S, Oizumi T, Fukao A, Kubota I, Kawata S, Kato T. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM. Biochem Biophys Res Commun, 2008, 374(3): 576–580
Schelleman H, Klungel O H, Witteman J C, Breteler M M, Hofman A, van Duijn C M, de Boer A, Stricker B H. Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics J, 2007, 7(5): 346–352
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, DH., Liu, DP., Wang, LY. et al. Genetic variants in the ADD1 and GNB3 genes and blood pressure response to potassium supplementation. Front. Med. China 4, 59–66 (2010). https://doi.org/10.1007/s11684-010-0015-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-010-0015-8